trial · primary record
Biospecimen Collection
Desmoplastic Small Round Cell Tumor
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 55 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Maximum tolerated dose and/or recommended phase 2 dose of DS-8201a in children at least 2 to less than 12 years old with recurrent or refractory Wilms tumor (WT) or desmoplastic small round cell tumor (DSRCT) (Phase 1) |
| Registry ID | NCT04616560 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:10.099Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04616560
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biospecimen Collection · compound